|
TOP NEWS
Investors Say Teva Can't Get Early Win In Price-Fixing Suit
By Matthew Santoni
Investors guided by Highfields Capital told a Connecticut federal court that Teva Pharmaceuticals can't escape their claims that its alleged collusion with other drugmakers to artificially inflate the price of generic drugs also inflated stock prices, reasoning that Teva executives falsely attributed the company's performance to factors other than the alleged price-fixing.
Memorandum attached |
Read full article »
| Save to favorites »
INTERNATIONAL
MERGER REVIEW
LITIGATION
Iowa Can't Block Schwab's Antitrust Deal, 5th Circ. Told
By Katryna Perera
A group of investors who settled with The Charles Schwab Corp. in an antitrust suit over the financial services company's merger with TD Ameritrade has urged the Fifth Circuit to dismiss an appeal filed by the state of Iowa, which had previously objected to the settlement's lack of monetary benefit to the class and proposed attorney payouts.
Motion attached |
Read full article »
| Save to favorites »
EXPERT ANALYSIS
LEGAL INDUSTRY
|